Cite
Evaluation of Commercial Products for Colistin and Polymyxin B Susceptibility Testing for mcr-Positive and Negative Escherichia coli and Klebsiella pneumoniae in China
MLA
Zhang Q, et al. “Evaluation of Commercial Products for Colistin and Polymyxin B Susceptibility Testing for Mcr-Positive and Negative Escherichia Coli and Klebsiella Pneumoniae in China.” Infection and Drug Resistance, vol. ume 16, Feb. 2023, pp. 1171–81. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.33dc051f6f4046ceb4371f58446296b6&authtype=sso&custid=ns315887.
APA
Zhang Q, Yan W, Zhu Y, Jing N, Wang S, Yuan Y, Ma B, Xu J, Chu Y, Zhang J, Ma Q, Wang B, Xu W, Zhu L, Sun Y, Shi C, Fang J, Li Y, & Liu S. (2023). Evaluation of Commercial Products for Colistin and Polymyxin B Susceptibility Testing for mcr-Positive and Negative Escherichia coli and Klebsiella pneumoniae in China. Infection and Drug Resistance, ume 16, 1171–1181.
Chicago
Zhang Q, Yan W, Zhu Y, Jing N, Wang S, Yuan Y, Ma B, et al. 2023. “Evaluation of Commercial Products for Colistin and Polymyxin B Susceptibility Testing for Mcr-Positive and Negative Escherichia Coli and Klebsiella Pneumoniae in China.” Infection and Drug Resistance ume 16 (February): 1171–81. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.33dc051f6f4046ceb4371f58446296b6&authtype=sso&custid=ns315887.